View study details on ClinicalTrials.gov
Subjects with generalized myasthenia gravis (gMG) who have needed at least two immunosuppressive drugs, or one immunosuppressive drug and regular plasma exchange or IVIG to control symptoms.
Contact site for start date.
Please contact ClinicalResearch@sutterhealth.org about Study Refractory MG.
June 01, 2018